Decreased food intake does not completely account for adiposity reduction after ob protein infusion.
The effects of recombinantly produced ob protein were compared to those of food restriction in normal lean and genetically obese mice. Ob protein infusion into ob/ob mice resulted in large decreases in body and fat-depot weight and food intake that persisted throughout the study. Smaller decreases in body and fat-depot weights were observed in vehicle-treated ob/ob mice that were fed the same amount of food as that consumed by ob protein-treated ob/ob mice (pair feeding). In lean mice, ob protein infusion significantly decreased body and fat-depot weights, while decreasing food intake to a much lesser extent than in ob/ob mice. Pair feeding of lean vehicle-treated mice to the intake of ob protein-treated mice did not reduce body fat-depot weights. The potent weight-, adipose-, and appetite-reducing effects exerted by the ob protein in ob protein-deficient mice (ob/ob) confirm hypotheses generated from early parabiotic studies that suggested the existence of a circulating satiety factor of adipose origin. Pair-feeding studies provide compelling evidence that the ob protein exerts adipose-reducing effects in excess of those induced by reductions in food intake.
Levin
N
N
Department of Pulmonary Research, Genentech, Inc., South San Francisco,CA 94080, USA.
Nelson
C
C
Gurney
A
A
Vandlen
R
R
de Sauvage
F
F
D000273:Adipose Tissue; D000818:Animals; D001066:Appetite / Q000187:drug effects*; D001786:Blood Glucose / Q000032:analysis; D002149:Energy Intake; D005260:Female; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D020738:Leptin; D008055:Lipids / Q000097:blood; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D009765:Obesity / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D009929:Organ Size / Q000187:drug effects; D011506:Proteins / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D015431:Weight Loss / Q000187:drug effects*
D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D008055:Lipids; D011506:Proteins; D011994:Recombinant Proteins